Connect with us

Hi, what are you looking for?

THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle



Meditation app Headspace set to unravel FDA-approved programs

Is meditation the new medication?

Headspace is a mindfulness and meditation app in which users can listen to meditation sessions and sounds anytime and anywhere.

The London-based company was founded in just 2010, yet it already has 30 million users and is worth $250 million. And the executives have nothing but expansion in mind.

On Wednesday, the company announced that the creation of a subsidiary called Headspace Health, which will unravel prescription-level meditation techniques and practices. Chief science officer Megan Jones Bell told Business Insider that the company will begin clinical trials this summer, aiming to acquire FDA approval on their first prescribed product.

Presently, meditation apps are extremely popular among healthy people – even Twitter CEO Jack Dorsey regularly goes on meditation retreats. However, very few people use meditation techniques for illness recovery purposes. Headspace plans to do just that.

The company already has a team working with research institutions like the University of California, Berkeley, and Britain’s National Health Service. According to Jones Bell, they are currently tackling twelve different mental and physical conditions.

Studies have already proven many benefits of meditation, such as increased focus, patience, ability to relate with others, and less fatigue. However, Headspace will need to work closely with the FDA to roll out any programs for diagnosed diseases.

Headspace’s target is 2020, and if the company continues with their reported progress, they could open doors for a new wave of treatment.


Featured image via Pexels/Prasanth Inturi

Comment Template

You May Also Like


On Monday, Japan’s Astellas Pharma (4503.T) announced its largest purchase, buying U.S. pharmaceutical Iveric Bio Inc. for $5.9 billion to gain access to ophthalmic...

Breaking News

Pfizer’s RSV shot access commitment faces challenges. Global health authorities told Reuters that Pfizer Inc (PFE.N) has vowed to provide crucial new medicines faster...


GSK (GSK.L) will buy Bellus Health Inc. (BLU.TO) for $2 billion in cash as it bets on respiratory medicines. GSK investors worry about whether...

Breaking News

On Tuesday, British junior Doctors launched a four-day protest over wages, threatening patient safety. In the latest disruption to the state-funded National Health Service,...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.